Logo Image
News|Articles|August 3, 2026

8 Nephrology Headlines You Missed in July 2026

Fact checked by: Chelsie Derman

Nephrology in July 2026: FDA approvals for atacicept, iptacopan, and Furoscix in IgAN/CKD, plus new IgAN and CKD trial data.

July was a landmark month for nephrology, headlined by a wave of US Food and Drug Administration (FDA) regulatory action in IgA nephropathy (IgAN) and a first-ever regulatory pathway forming for primary membranous nephropathy (pMN).